SCHEMBL10238101

SCHEMBL10238101

Cc1oc(-c2ccc(Cl)cc2)nc1C1C(=O)[C@@H]2CC[C@@H](C2)C1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TARBP2 Q15633 1/20 0.41
▸ POLB P06746 4/20 0.39
▸ ALDH1A1 P00352 4/20 0.38
▸ LMNA P02545 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.37
▸ IKBKB O14920 1/20 0.37
▸ ALOX15B O15296 1/20 0.37
▸ PPARA Q07869 1/20 0.37
▸ TP53 P04637 4/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ HTT P42858 2/20 0.37
▸ NOTUM Q6P988 2/20 0.37
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ SLC6A3 Q01959 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13041538 0.75 TARBP2 (0.42) TARBP2POLBALDH1A1LMNAKDM4E
SCHEMBL10237934 0.74 RAB9A (0.40) POLBALDH1A1KDM4ESMN1; SMN2NOTUM
SCHEMBL608580 0.74 SLC6A3 (0.36) POLBKDM4EHTTSLC6A3MAPT
SCHEMBL10238098 0.73 NPC1 (0.39) ALDH1A1KDM4EPPARATP53SMN1; SMN2
SCHEMBL25337989 0.72 ACHE (0.44) POLBALDH1A1KDM4EHSD17B10IKBKB
SCHEMBL10238105 0.72 GPBAR1 (0.41) POLBALDH1A1KDM4ENPC1SLC6A3
SCHEMBL10238015 0.71 ALDH1A1 (0.40) POLBALDH1A1KDM4ESMN1; SMN2NOTUM
SCHEMBL10237969 0.69 SMN1; SMN2 (0.46) POLBALDH1A1LMNAKDM4ESMN1; SMN2
SCHEMBL10238001 0.69 ALDH1A1 (0.39) POLBALDH1A1KDM4ETP53SMN1; SMN2
SCHEMBL16215992 0.69 HRH3 (0.41) POLBALDH1A1KDM4ESMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2176222-B1 NOVEL HERBICIDES SYNGENTA LTD (GB) 2014-11-05 — — EP disclosed
US-8541594-B2 — — 2013-09-24 — — US disclosed
US-8541594-B2 — — 2013-09-24 — — US disclosed
US-20120040826-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2012-02-16 — — US disclosed
US-20120040826-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2012-02-16 — — US disclosed
WO-2009015877-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2009-02-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120040826-A1 NOVEL HERBICIDES DDT, HDHD5, DDC TARBP2 3668/4885POLB 3898/4885ALDH1A1 294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback